A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: Results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)

American Heart Journal

Volumn 159, Issue 6, 2010, Pages 987.e1-987.e7

  Merz, C Noel Bairey ^a   Olson, Marian B ^b   McClure, Candace ^b   Yang, Yu Ching ^a   Symons, James ^c   Sopko, George ^d   Kelsey, Sheryl F ^b   Handberg, Eileen ^e   Johnson, B Delia ^b   Cooper DeHoff, Rhonda M ^e   Sharaf, Barry ^f   Rogers, William J ^g   Pepine, Carl J ^e  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c NIH ^*

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f RHODE ISLAND HOSPITAL   (United States)

^g University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; PLACEBO;

ADULT; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; EXERCISE; FEMALE; HEART MUSCLE ISCHEMIA; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; LOW DRUG DOSE; NIGHT SWEAT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SIDE EFFECT; SOCIAL AVOIDANCE BEHAVIOR; SOCIAL PSYCHOLOGY; THORAX PAIN; TREATMENT DURATION; VAGINAL DRYNESS;

EID: 77953015712     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.03.024     Document Type: Article

References (44)

1. Panza J.A. Myocardial ischemia and the pains of the heart. N Engl J Med 346 (2002) 1934-1935
2. Cannon III R.O. Does coronary endothelial dysfunction cause myocardial ischemia in the absence of obstructive coronary artery disease. Circulation 96 (1997) 3251-3254
3. Williams J.K., Adams M.R., and Klopfenstein H.S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81 (1990) 1680-1687
4. Williams J.K., Shively C.A., and Clarkson T.B. Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis. Circulation 90 (1994) 983-987
5. Gilligan D.M., Quyyumi A.A., and Cannon III R.O. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89 (1994) 2545-2551
6. Reis S.E., Gloth S.T., Blumenthal R.S., et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89 (1994) 52-60
7. Merz C.N., Kelsey S.F., Pepine C.J., et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 33 (1999) 1453-1461
8. Sharaf B.L., Pepine C.J., Kerensky R.A., et al. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol 87 (2001) 937-941
9. The manual of laboratory operations 1. Lipid and lipoprotein analysis. Bethesda: Lipid Research Clinics Program. National Institutes of Health. DHEW Publication No. 75-628; 1974.
10. Barrett-Connor E., and Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 311 (1995) 1193-1196
11. Helmer D.C., Ragland D.R., and Syme S.L. Hostility and coronary artery disease. Am J Epidemiol 133 (1991) 112-122
12. Naughton M.J., Shumaker S.A., Anderson R.T., et al. Psychological aspects of health-related quality of life measurement: tests and scales (1996), Lippincott-Raven Publishers, Philadelphia
13. Mandler G., Mandler J.M., and Uviller E.T. Autonomic feedback: the perception of autonomic activity. J Abnorm Psychol 56 (1958) 367-373
14. Ware J.E., Kosinski M., and Gandek B. SF-36 Health Survey. Manual and interpretation guide (1993), Quality Metric Inc., Lincoln
15. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
16. Hilditch J.R., Lewis J., Peter A., et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 24 (1996) 161-175
17. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
18. Rosano G.M., Sarrel P.M., Poole-Wilson P.A., et al. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342 (1993) 133-136
19. Olson M.B., Kelsey S.F., Matthews K., et al. Symptoms, myocardial ischaemia and quality of life in women: results from the NHLBI-sponsored WISE Study. Eur Heart J 24 (2003) 1506-1514
20. Albertsson P.A., Emanuelsson H., and Milsom I. Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X. Int J Cardiol 54 (1996) 13-20
21. Adamson D.L., Webb C.M., and Collins P. Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms. Menopause 8 (2001) 233-238
22. Rosano G.M., and Peters N.S. Lefroy D, et al. 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 28 (1996) 1500-1505
23. Gerhard M., Walsh B.W., Tawakol A., et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 98 (1998) 1158-1163
24. Herrington D.M., Werbel B.L., Riley W.A., et al. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease. J Am Coll Cardiol 33 (1999) 2030-2037
25. Koh K.K., Cardillo C., Bui M.N., et al. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation 99 (1999) 354-360
26. Herrington D.M., Reboussin D.M., Brosnihan K.B., et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343 (2000) 522-529
27. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280 (1998) 605-613
28. Waters D.D., Alderman E.L., Hsia J., et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 288 (2002) 2432-2440
29. Lobo R.A. Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women: results from 2 large clinical trials. Arch Intern Med 164 (2004) 482-484
30. Rossouw J.E., Prentice R.L., Manson J.E., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297 (2007) 1465-1477
31. Campisi R., Nathan L., Pampaloni M.H., et al. Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration. Circulation 105 (2002) 425-430
32. Johnson B.D., Shaw L.J., Buchthal S.D., et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 (2004) 2993-2999
33. Buchthal S.D., den Hollander J.A., Merz C.N., et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 342 (2000) 829-835
34. Halcox J.P., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 (2002) 653-658
35. Kaski J.C., Rosano G.M., Collins P., et al. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 25 (1995) 807-814
36. Kemp H.G., Kronmal R.A., Vlietstra R.E., et al. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 7 (1986) 479-483
37. Lichtlen P.R., Bargheer K., and Wenzlaff P. Long-term prognosis of patients with anginalike chest pain and normal coronary angiographic findings. J Am Coll Cardiol 25 (1995) 1013-1018
38. Shaw L.J., Merz C.N., Pepine C.J., et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Circulation 114 (2006) 894-904
39. Johnson B.D., Shaw L.J., Pepine C.J., et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J 27 (2006) 1408-1415
40. von Mering G.O., Arant C.B., Wessel T.R., et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 (2004) 722-725
41. Lanza GA, Colonna G, Pasceri V, et al. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol 1999;84:854-6, A8.
42. Lerman A., Burnett Jr. J.C., Higano S.T., et al. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 97 (1998) 2123-2128
43. RO Cannon I.I.I., Quyyumi A.A., Mincemoyer R., et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 330 (1994) 1411-1417
44. Eriksson B.E., Tyni-Lenne R., Svedenhag J., et al. Physical training in syndrome X: physical training counteracts deconditioning and pain in syndrome X. J Am Coll Cardiol 36 (2000) 1619-1625